{"id":"W2919509343","doi":"10.1182/blood-2018-99-116750","title":"Prognostic Impact of Germ-Line FCGR2A (H131R), FCGR3A (F158V), and FCGR2B (I232T) Single Nucleotide Polymorphisms in Lymphoma Patients Treated with Obinutuzumab or Rituximab in Combination with Chemotherapy: Results from the Phase III GALLIUM and GOYA Clinical Trials","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Obinutuzumab; Rituximab; Medicine; Internal medicine; Oncology; Lymphoma; Single-nucleotide polymorphism; Ibrutinib; Chemotherapy regimen; Chemotherapy; Cancer research; Biology; Genotype; Leukemia; Genetics; Chronic lymphocytic leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002028285,0.000377538,0.000833714,0.0001673897,0.0001900255,0.0008841071,0.0004504635,0.0007540624,0.001325813],"category_scores_gemma":[0.002265935,0.0001695539,0.001302208,0.0004951068,0.000349195,0.0004162533,0.0002834606,0.0008136046,0.0001822435],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004216752,"about_ca_system_score_gemma":0.0002849088,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004394519,"about_ca_topic_score_gemma":0.0007925349,"domain_scores_codex":[0.9990749,0.0005046166,0.00009499413,0.0001812425,0.00007465866,0.00006942838],"domain_scores_gemma":[0.9975407,0.001059536,0.0008538648,0.000126092,0.0001132956,0.0003065344],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2374329,0.001186349,0.6470802,0.001612376,0.01334089,0.0003401824,0.000248351,0.001901737,0.01814196,0.0003311393,0.002920763,0.07546312],"study_design_scores_gemma":[0.03861652,0.02389785,0.9048703,0.0003727815,0.01809669,0.0009193924,0.0001602376,0.002568917,0.004279374,0.0007936939,0.005357544,0.00006681275],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9902957,0.008160509,0.0001463512,0.0003276537,0.00002999809,0.00005781887,0.0004547256,0.000004879479,0.0005222199],"genre_scores_gemma":[0.9980946,0.0007494359,0.0001588279,0.0002180163,0.00004176272,0.00005635723,0.000531957,0.000003689836,0.0001452525],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002028285,"threshold_uncertainty_score":0.01072675,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06400395745196007,"score_gpt":0.3742934563001233,"score_spread":0.3102894988481632,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}